Simplex Trading’s Tempest Therapeutics TPST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-638
Closed -$6K 9698
2024
Q4
$6K Buy
638
+576
+929% +$7.43K ﹤0.01% 7543
2024
Q3
$1K Sell
62
-1,884
-97% -$38.6K ﹤0.01% 8289
2024
Q2
$55K Buy
1,946
+1,031
+113% +$44.6K ﹤0.01% 5993
2024
Q1
$46K Sell
915
-562
-38% -$28.4K ﹤0.01% 6343
2023
Q4
$84K Buy
+1,477
New +$69.9K ﹤0.01% 5561
2021
Q4
Sell
-1,169
Closed -$168K 11439
2021
Q3
$168K Hold
1,169
﹤0.01% 5876
2021
Q2
$169K Buy
1,169
+1,166
+38,867% +$262K ﹤0.01% 5965
2021
Q1
$60K Buy
3
+2
+200% +$808 ﹤0.01% 6389
2020
Q4
$54K Buy
+1
New +$346 ﹤0.01% 6097
2020
Q3
Sell
-1
Closed -$36K 8524
2020
Q2
$36K Buy
+1
New +$399 ﹤0.01% 5779
2020
Q1
Hold
0
6056
2017
Q4
Hold
0
-$4K 6693
2017
Q3
Hold
0
4615
2016
Q4
Hold
0
-$1K 6531
2016
Q3
Hold
0
5443
2016
Q2
Hold
0
-$1K 6458
2016
Q1
Hold
0
5249
2015
Q3
Hold
0
-$3K 6203
2015
Q2
Hold
0
4111
2015
Q1
Hold
0
2640

Other funds holding TPST

Simplex Trading's TPST Position: Q2 2025 in Review

Simplex Trading sold out of Tempest Therapeutics (TPST) in Q2 2025, closing a stake of 1,571 shares — an estimated $15K sold.

Simplex Trading first reported a position in TPST in Q1 2015 and held it in 14 quarters. The position peaked at $296K in Q4 2023. 18 funds tracked by Wall St. Rank hold TPST as of Q2 2025.

  • Simplex Trading reported no remaining Tempest Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Simplex Trading sold 1,571 Tempest Therapeutics shares in Q2 2025, an estimated $15K.
  • Simplex Trading first reported a position in Tempest Therapeutics in Q1 2015 and held it in 14 quarters.
  • Simplex Trading's Tempest Therapeutics position peaked at $296K in Q4 2023.
  • 18 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.